Docosahexaenoic acid in the diet: Its importance in maintenance and restoration of neural membrane function

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 70, Issue 4, 2004, Pages 361-372

  Horrocks, Lloyd A ^a   Farooqui, Akhlaq A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ION CHANNEL; LIPID; LONG CHAIN FATTY ACID; MEMBRANE ENZYME; MEMBRANE PHOSPHOLIPID; OMEGA 3 FATTY ACID;

AGING; ALZHEIMER DISEASE; APOPTOSIS; BILAYER MEMBRANE; BRAIN PROTECTION; CENTRAL NERVOUS SYSTEM; CHEMICAL COMPOSITION; CONFERENCE PAPER; DISORDERS OF PEROXISOMAL FUNCTIONS; ENZYME ACTIVITY; FAT INTAKE; GENE EXPRESSION REGULATION; HUMAN; HYPERACTIVITY; IMMUNOMODULATION; INFLAMMATION; MEMBRANE FLUIDITY; MEMORY; MODULATION; NERVE CELL MEMBRANE; NERVE CELL PLASTICITY; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; NUTRITIONAL DEFICIENCY; PHASE TRANSITION; PHASE TRANSITION TEMPERATURE; PRIORITY JOURNAL; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TEMPERATURE; THICKNESS;

EID: 1842453667     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2003.12.011     Document Type: Conference Paper

References (130)

1. S.M. Innis, Essential fatty acids in growth and development, Prog. Lipid Res. 30 (1991) 39-103.
2. L. Lauritzen, H.S. Hansen, M.H. Jorgensen, K.F. Michaelsen, The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina, Prog. Lipid Res. 40 (2001) 1-94.
3. H. Hamano, J. Nabekura, M. Nishikawa, T. Ogawa, Docosahexaenoic acid reduces GABA response in substantia nigra neuron of rat, J. Neurophysiol. 75 (1996) 1264-1270.
4. B.L. Scott, N.G. Bazan, Membrane docosahexaenoate is supplied to the developing brain and retina by the liver, Proc. Natl. Acad. Sci. USA 86 (1989) 2903-2907.
5. S.M. Innis, R.A. Dyer, Brain astrocyte synthesis of docosahexaenoic acid from n-3 fatty acids is limited at the elongation of docosapentaenoic acid, J. Lipid Res. 43 (2002) 1529-1536.
6. S.A. Moore, Local synthesis and targeting of essential fatty acids at the cellular interface between blood and brain: a role for cerebral endothelium and astrocytes in the accretion of CNS docosahexaenoic acid, World Rev. Nutr. Diet 75 (1994) 128-133.
7. S.A. Moore, E. Yoder, S. Murphy, G.R. Dutton, A.A. Spector, Astrocytes, not neurons, produce docosahexaenoic acid (22:6 omega-3) and arachidonic acid (20:4 omega-6), J. Neurochem. 56 (1991) 518-524.
8. D.E. Williard, S.D. Harmon, T.L. Kaduce, M. Preuss, S.A. Moore, M.E.C. Robbins, A.A. Spector, Docosahexaenoic acid synthesis from n-3 polyunsaturated fatty acids in differentiated rat brain astrocytes, J. Lipid Res. 42 (2001) 1368-1376.
9. S.I. Rapoport, M.C.J. Chang, A.A. Spector, Delivery and turnover of plasma-derived essential PUFAs in mammalian brain, J. Lipid Res. 42 (2001) 678-685.
10. A.A. Farooqui, L.A. Horrocks, T. Farooqui, Deacylation and reacylation of neural membrane glycerophospholipids, J. Mol. Neurosci. 14 (2000) 123-135.
11. 2, and docosahexaenoic acid turnover in brain tissue, J. Mol. Neurosci. 16 (2001) 263-272.
12. 2, and signal transduction, Brain Res. Rev. 21 (1995) 152-161.
13. 2 during the hydrolysis of diacyl-and alkenylacylglycerophosphoethanolamine, Biochim. Biophys. Acta Lipids Lipid Metab. 1212 (1994) 211-216.
14. S. Hong, K. Gronert, P.R. Devchand, R.L. Moussignac, C.N. Serhan, Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells - Autacoids in anti-inflammation, J. Biol. Chem. 278 (2003) 14677-14687.
15. H.O. Bang, J. Dyerberg, N. Hjorne, The composition of food consumed by Greenland eskimos, Acta Med. Scand. 200 (1976) 69-73.
16. P. Bougnoux, n-3 Polyunsaturated fatty acids and cancer, Curr. Opin. Clin. Nutr. Metab. Care 2 (1999) 121-126.
17. P.D. Terry, T.E. Rohan, L. Wolk, Intakes of fish and marine fatty acids and the risks of cancers of the breast and pro-state and of other hormone-related cancers: a review of the epidemiologic evidence, Am. J. Clin. Nutr. 77 (2003) 532-543.
18. L.A. Horrocks, Y.K. Yeo, Health benefits of docosahexaenoic acid (DHA), Pharmacol. Res. 40 (1999) 211-225.
19. M. Neuringer, G.J. Anderson, W.E. Connor, The essentiality of n-3 fatty acids for the development and function of the retina and brain, Annu. Rev. Nutr. 8 (1988) 517-541.
20. M. Neuringer, W.E. Connor, N-3 fatty acids in the brain and retina: evidence for their essentiality, Nutr. Rev. 44 (1986) 285-294.
21. R.E. Anderson, D.J. Landis, P.A. Dudley, Essential fatty acid deficiency and renewal of rod outer segments in the albino rat, Invest. Ophthalmol. 15 (1976) 232-236.
22. W.E. Connor, M. Neuringer, D.S. Lin, Dietary effects on brain fatty acid composition: the reversibility of n-3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain, erythrocytes, and plasma of rhesus monkeys, J. Lipid Res. 31 (1990) 237-247.
23. J.D. Fernstrom, Effects of dietary polyunsaturated fatty acids on neuronal function, Lipids 34 (1999) 161-169.
24. S. Yehuda, S. Rabinovitz, R.L. Carasso, D.I. Mostofsky, The role of polyunsaturated fatty acids in restoring the aging neuronal membrane, Neurobiol. Aging 23 (2002) 843-853.
25. M. Hashimoto, K. Shinozuka, S. Gamoh, Y. Tanabe, M.S. Hossain, Y.M. Kwon, N. Hata, Y. Misawa, M. Kunitomo, S. Masumura, The hypotensive effect of docosahexaenoic acid is associated with the enhanced release of ATP from the caudal artery of aged rats, J. Nutr. 129 (1999) 70-76.
26. G. Barcelo-Coblijn, K. Kitajka, L.G. Puskas, E. Hogyes, A. Zvara, L. Hackler Jr, T. Farkas, Gene expression and molecular composition of phospholipids in rat brain in relation to dietary n-6 to n-3 fatty acid ratio, Biochim. Biophys. Acta 1632 (2003) 72-79.
27. T. Farkas, K. Kitajka, E. Fodor, I. Csengeri, E. Lahdes, Y.K. Yeo, Z. Krasznai, J.E. Halver, Docosahexaenoic acid-containing phospholipid molecular species in brains of vertebrates, Proc. Natl. Acad. Sci. USA 97 (2000) 6362-6366.
28. K. Kitajka, L.G. Puskas, A. Zvara, L.J. Hackler, G. Barcelo-Coblijn, Y.K. Yeo, T. Farkas, The role of n-3 polyunsaturated fatty acids in brain: modulation of rat brain gene expression by dietary n-3 fatty acids, Proc. Natl. Acad. Sci. USA 99 (2002) 2619-2624.
29. L.G. Puskas, K. Kitajka, C. Nyakas, G. Barcelo-Coblijn, T. Farkas, Short-term administration of omega 3 fatty acids from fish oil results in increased transthyretin transcription in old rat hippocampus, Proc. Natl. Acad. Sci. USA 100 (2003) 1580-1585.
30. L.S. Alexander-North, J.A. North, K.P. Kiminyo, G.R. Buettner, A.A. Spector, Polyunsaturated fatty acids increase lipid radical formation induced by oxidant stress in endothelial cells, J. Lipid Res. 35 (1994) 1773-1785.
31. P. Green, S. Glozman, E. Yavin, Ethyl docosahexaenoate-associated decrease in fetal brain lipid peroxide production is mediated by activation of prostanoid and nitric oxide pathways, Biochim. Biophys. Acta. Mol. Cell. Biol. Lipids 1531 (2001) 156-164.
32. S. Chalon, S. Delion-Vancassel, C. Belzung, D. Guilloteau, A.M. Leguisquet, J.C. Besnard, G. Durand, Dietary fish oil affects monoaminergic neurotransmission and behavior in rats, J. Nutr. 128 (1998) 2512-2519.
33. S. Delion, S. Chalon, D. Guilloteau, B. Lejeune, J.C. Besnard, G. Durand, Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or an n-3 polyunsaturated fatty acid-deficient diet, J. Lipid Res. 38 (1997) 680-689.
34. L. Zimmer, S. Delpal, D. Guilloteau, J. Aioun, G. Durand, S. Chalon, Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex, Neurosci. Lett. 284 (2000) 25-28.
35. L. Zimmer, S. Delion-Vancassel, G. Durand, D. Guilloteau, S. Bodard, J.C. Besnard, S. Chalon, Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids, J. Lipid Res. 41 (2000) 32-40.
36. S. Chalon, S. Vancassel, L. Zimmer, D. Guilloteau, G. Durand, Polyunsaturated fatty acids and cerebral function: focus on monoaminergic neurotransmission, Lipids 36 (2001) 937-944.
37. L. Zimmer, S. Vancassel, S. Cantagrel, P. Breton, S. Delamanche, D. Guilloteau, G. Durand, S. Chalon, The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids, Am. J. Clin. Nutr. 75 (2002) 662-667.
38. M. Minami, S. Kimura, T. Endo, N. Hamaue, M. Hirafuji, H. Togashi, M. Matsumoto, M. Yoshioka, H. Saito, S. Watanabe, T. Kobayashi, H. Okuyama, Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats, Pharmacol. Biochem. Behav. 58 (1997) 1123-1129.
39. S. Aid, S. Vancassel, C. Poumes-Ballihaut, S. Chalon, P. Guesnet, M. Lavialle, Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus, J. Lipid Res. 44 (2003) 1545-1551.
40. E. Hogyes, C. Nyakas, A. Kiliaan, T. Farkas, B. Penke, P.G. Luiten, Neuroprotective effect of developmental docosahexaenoic acid supplement against excitotoxic brain damage in infant rats, Neuroscience 119 (2003) 999-1012.
41. M. Vreugdenhil, C. Bruehl, R.A. Voskuyl, J.X. Kang, A. Leaf, W.J. Wadman, Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons, Proc. Natl. Acad. Sci. USA 93 (1996) 12559-12563.
42. +-ATPase isoenzymes of brain membranes in the adult rat, J. Nutr. Biochem. 10 (1999) 230-236.
43. +-ATPase isoenzymes in whole brain membranes, J. Neurochem. 60 (1993) 246-252.
44. +-ATPase isoenzymes of weaned and adult rats, J. Neurochem. 62 (1994) 1560-1569.
45. +-ATPase activity at suboptimal concentrations of ATP, Biol. Pharm. Bull. 18 (1995) 664-670.
46. H. Obermeier, N. Hrboticky, A. Sellmayer, Differential effects of polyunsaturated fatty acids on cell growth and differentiation of premonocytic U937 cells, Biochim. Biophys. Acta 1266 (1995) 179-185.
47. 2 to the nuclear envelope elicits topographically localized phospholipid hydrolysis, Biochem. J. 318 (1996) 797-803.
48. S.J. Slater, M.B. Kelly, M.D. Yeager, J. Larkin, C. Ho, C.D. Stubbs, Polyunsaturation in cell membranes and lipid bilayers and its effects on membrane proteins, Lipids 31 (Suppl) (1996) S189-S192.
49. M.C. Garcia, G. Ward, Y.C. Ma, N. Salem Jr, H.Y. Kim, Effect of docosahexaenoic acid on the synthesis of phosphatidylserine in rat brain in microsomes and C6 glioma cells, J. Neurochem. 70 (1998) 24-30.
50. N. Salem, T. Shingu, H.-Y. Kim, F. Hullin, P. Bougnoux, J.W. Karanian, Aberrations in membrane structures and function, in: M.L. Karnovsky, L. Bolis, A. Leaf (Eds.), Biological Membranes, Alan R. Liss, New York, 1988, pp. 319-333.
51. M. Nishikawa, S. Kimura, N. Akaike, Facilitatory effect of docosahexaenoic acid on N-methyl-D-aspartate response in pyramidal neurones of rat cerebral cortex, J. Physiol. (London) 475 (1994) 83-93.
52. J.S. Poling, J.W. Karanian, N. Salem Jr., S. Vicini, Time-and voltage-dependent block of delayed rectifier potassium channels by docosahexaenoic acid, Mol. Pharmacol. 47 (1995) 381-390.
53. Y.F. Xiao, X.Y. Li, Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation, Brain Res. 846 (1999) 112-121.
54. C. Young, P.W. Gean, L.C. Chiou, Y.Z. Shen, Docosahexaenoic acid inhibits synaptic transmission and epileptiform activity in the rat hippocampus, Synapse 37 (2000) 90-94.
55. D.B. Jump, Dietary polyunsaturated fatty acids and regulation of gene transcription, Curr. Opin. Lipidol. 13 (2002) 155-164.
56. I. Issemann, R.A. Prince, J.D. Tugwood, S. Green, The peroxisome proliferator-activated receptor: retinoid x receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs, J. Mol. Endocrinol. 11 (1993) 37-47.
57. M. Gottlicher, A. Demoz, D. Svensson, P. Tollet, R.K. Berge, J.A. Gustafsson, Structural and metabolic requirements for activators of the peroxisome proliferator-activated receptor, Biochem. Pharmacol. 46 (1993) 2177-2184.
58. J.M. Ntambi, H. Bene, Polyunsaturated fatty acid regulation of gene expression, J. Mol. Neurosci. 16 (2001) 273-278.
59. B.E. Cowing, K.E. Saker, Polyunsaturated fatty acids and epidermal growth factor receptor/mitogen-activated protein kinase signaling in mammary cancer, J. Nutr. 131 (2001) 1125-1128.
60. P.C. Calder, Dietary fatty acids and the immune system. Nutr. Rev. 56 (1998) S70-S83.
61. D. Wu, S.N. Meydani, N-3 polyunsaturated fatty acids and immune function, Proc. Nutr. Soc. 57 (1998) 503-509.
62. P.C. Calder, R.F. Grimble, Polyunsaturated fatty acids, inflammation and immunity, Eur. J. Clin. Nutr. 56 (2002) S14-S19.
63. E.J. Corey, C. Shih, J.R. Cashman, Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis, Proc. Natl. Acad. Sci. USA 80 (1983) 3581-3584.
64. M.J. James, R.A. Gibson, L.G. Cleland, Dietary polyunsaturated fatty acids and inflammatory mediator production, Am. J. Clin. Nutr. 71 (2000) 343S-348S.
65. V.L. Marcheselli, S. Hong, W.J. Lukiw, X.H. Tian, K. Gronert, A. Musto, M. Hardy, J.M. Gimenez, N. Chiang, C.N. Serhan, N.G. Bazan, Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression, J. Biol. Chem. 278 (2003) 43807-43817.
66. C. Song, Effects of n-3 fatty acids on depressive symptoms induced by proinflammatory cytokines in animals, in: M. Peet, L. Glen, D.F. Horrobin (Eds.), Phospholipid Spectrum Disorders in Psychiatry and Neurology, Marius Press, Carnforth, Lancashire, 2003, pp. 415-422.
67. C. Chen, S. Tonegawa, Molecular genetic analysis of synaptic plasticity, activity-dependent neural development, learning, and memory in the mammalian brain, Annu. Rev. Neurosci. 20 (1997) 157-184.
68. M.A. Lynch, K.L. Voss, Membrane arachidonic acid concentration correlates with age and induction of long-term potentiation in the dentate gyrus in the rat, Eur. J. Neurosci. 6 (1994) 1008-1014.
69. B. McGahon, M.P. Clements, M.A. Lynch, The ability of aged rats to sustain long-term potentiation is restored when the age-related decrease in membrane arachidonic acid concentration is reversed, Neuroscience 81 (1997) 9-16.
70. B.M. McGahon, D.S.D. Martin, D.F. Horrobin, M.A. Lynch, Age-related changes in synaptic function: analysis of the effect of dietary supplementation with omega-3 fatty acids, Neuroscience 94 (1999) 305-314.
71. 2 inhibitor in rat hippocampal slices, Brit. J. Pharmacol. 132 (2001) 1417-1422.
72. K. Fujimoto, K. Yao, T. Miyazaki, H. Hirano, M. Nishikawa, S. Kimura, K. Murayama, M. Nonaka, The effect of dietary docosahexaenoate on the learning ability of rats, in: R.K. Chandra (Ed.), Health Effects of Fish and Fish Oils, The Netherlands, ARTS Biomedical, 1989, pp. 275-284.
73. N. Yamamoto, M. Saitoh, A. Moriuchi, M. Nomura, H. Okuyama, Effect of dietary alpha-linolenic/linoleate balance on brain lipid compositions and learning ability of rats, J. Lipid Res. 28 (1987) 144-151.
74. C. Young, P.W. Gean, S.P. Wu, C.H. Lin, Y.Z. Shen, Cancellation of low-frequency stimulation-induced long-term depression by docosahexaenoic acid in the rat hippocampus, Neurosci. Lett. 247 (1998) 198-200.
75. R.S. Zucker, Short-term synaptic plasticity, Annu. Rev. Neurosci. 12 (1989) 13-31.
76. N. Itokazu, Y. Ikegaya, M. Nishikawa, N. Matsuki, Bidirectional actions of docosahexaenoic acid on hippocampal neurotransmissions in vivo, Brain Res. 862 (2000) 211-216.
77. + channel (Kv1.5) by polyunsaturated fatty acids, Proc. Natl. Acad. Sci. USA 91 (1994) 1937-1941.
78. + channel blocker in the hippocampus, Nature 349 (1991) 67-69.
79. S. Favrelière, L. Barrier, G. Durand, S. Chalon, C. Tallineau, Chronic dietary n-3 polyunsaturated fatty acids deficiency affects the fatty acid composition of plasmenylethanolamine and phosphatidylethanolamine differently in rat frontal cortex, striatum, and cerebellum, Lipids 33 (1998) 401-407.
80. S. Favrelière, M.C. Perault, F. Huguet, D. De Javel, N. Bertrand, A. Piriou, G. Durand, DHA-enriched phospholipid diets modulate age-related alterations in rat hippocampus, Neurobiol. Aging 24 (2003) 233-243.
81. C.R. Jones, T. Arai, S.I. Rapoport, Evidence for the involvement of docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse, Neurochem. Res. 22 (1997) 663-670.
82. G. Barcelo-Coblijn, E. Hogyes, K. Kitajka, L.G. Puskas, A. Zvara, L. Hackler Jr., C. Nyakas, Z. Penke, T. Farkas, Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids, Proc. Natl. Acad. Sci. USA 100 (2003) 11321-11326.
83. S. Gamoh, M. Hashimoto, S. Hossain, S. Masumura, Chronic administration of docosahexaenoic acid improves the performance of radial arm maze task in aged rats, Clin. Exp. Pharmacol. Physiol. 28 (2001) 266-270.
84. N. Kotchabhakdi, R. Tipyasang, W. Thangnipon, N. Jutapukdeekun, C. Jindaduangratn, Effects of different dosages of docosahexaenoic acid (DHA) intake on maze-learning ability and densities of dendritic spines in rats, Soc. Neurosci. Abstracts (2003) Program No. 941.17.
85. M. Söderberg, C. Edlund, K. Kristensson, G. Dallner, Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease, Lipids 26 (1991) 421-425.
86. Z. Guan, Y. Wang, N.J. Cairns, P.L. Lantos, G. Dallner, P.J. Sindelar, Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease, J. Neuropathol. Exp. Neurol. 58 (1999) 740-747.
87. X.L. Han, D.M. Holtzman, D.W. McKeel Jr, Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry, J. Neurochem. 77 (2001) 1168-1180.
88. J.W. Pettegrew, K. Panchalingam, R.L. Hamilton, R.J. McClure, Brain membrane phospholipid alterations in Alzheimer's disease, Neurochem. Res. 26 (2001) 771-782.
89. K. Wells, A.A. Farooqui, L. Liss, L.A. Horrocks, Neural membrane phospholipids in Alzheimer disease, Neurochem. Res. 20 (1995) 1329-1333.
90. A.A. Farooqui, W.Y. Ong, L.A. Horrocks, Plasmalogens, docosahexaenoic acid, and neurological disorders, in: F. Roels, M. Baes, S. de Bies (Eds.), Peroxisomal Disorders and Regulation of Genes, Kluwer Academic/Plenum Publishers, London, 2003, pp. 335-354.
91. A.A. Farooqui, S.I. Rapoport, L.A. Horrocks, Membrane phospholipid alterations in Alzheimer disease: deficiency of ethanolamine plasmalogens, Neurochem. Res. 22 (1997) 523-527.
92. J.W. Pettegrew, Molecular insights into Alzheimer disease, Ann. NY Acad. Sci. 568 (1989) 5-28.
93. K.V. Subbarao, J.S. Richardson, L.C. Ang, Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro, J. Neurochem. 55 (1990) 342-345.
94. S. Kalmijn, E.J.M. Feskens, L.J. Launer, D. Kromhout, Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men, Am. J. Epidemiol. 145 (1997) 33-41.
95. R.P. Friedland, Fish consumption and the risk of Alzheimer disease: is it time to make dietary recommendations? Arch. Neurol. 60 (2003) 923-924.
96. M.C. Morris, D.A. Evans, J.L. Bienias, C.C. Tangney, D.A. Bennett, R.S. Wilson, N. Aggarwal, J. Schneider, Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease, Arch. Neurol. 60 (2003) 940-946.
97. E. Farkas, P.G.M. Luiten, Cerebral microvascular pathology in aging and Alzheimer's disease, Prog. Neurobiol. 64 (2001) 575-611.
98. S. Kimura, H. Saito, M. Minami, H. Togashi, N. Nakamura, K. Ueno, K. Shimamura, M. Nemoto, H. Parvez, Docosahexaenoic acid attenuated hypertension and vascular dementia in stroke-prone spontaneously hypertensive rats, Neurotoxicol. Teratol. 24 (2002) 683-693.
99. H. Tsukada, T. Kakiuchi, D. Fukumoto, S. Nishiyama, K. Koga, Docosahexaenoic acid (DHA) improves the age-related impairment of the coupling mechanism between neuronal activation and functional cerebral blood flow response: a pet study in conscious monkeys, Brain Res. 862 (2000) 180-186.
100. M. Hashimoto, S. Hossain, T. Shimada, K. Sugioka, H. Yamasaki, Y. Fujii, Y. Ishibashi, J.I. Oka, O. Shido, Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats, J. Neurochem. 81 (2002) 1084-1091.
101. G.P. Lim, F. Calon, F. Yang, O. Ubeda, M. Simmons, K. Hsiao Ashe, S.A. Frautschy, G.M. Cole, Diets enriched with polyunsaturated DHA (docosahexaenoic acid) can lower amyloid levels and plaque burden in an Alzheimer's disease mouse model, Soc. Neurosci. Abstracts (2003) Program No. 201.25.
102. M.C. de Wilde, I. Leenders, L.M. Broersen, A.A.M. Kuipers, E.M. van der Beek, A.J. Kiliaan, The omega-3 fatty acid docosahexaenoic acid (DHA) inhibits the formation of beta amyloid in CHO7PA2 cells, Soc. Neurosci. Abstracts (2003) Program No. 730.11.
103. H.Y. Kim, M. Akbar, A. Lau, L. Edsall, Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect, J. Biol. Chem. 275 (2000) 35215-35223.
104. E. Kishida, M. Yano, M. Kasahara, Y. Masuzawa, Distinctive inhibitory activity of docosahexaenoic acid against sphingosine-induced apoptosis, Biochim. Biophys. Acta Lipids Lipid Metab. 1391 (1998) 401-408.
105. M.K. Oehler, M. Sütterlin, H. Caffier, CASA and CA 125 in diagnosis and follow-up of advanced ovarian cancer, Anticancer Res. 19 (1999) 2513-2518.
106. N.P. Rotstein, M.I. Aveldaño, F.J. Barrantes, A.M. Roccamo, L.E. Politi, Apoptosis of retinal photoreceptors during development in vitro: protective effect of docosahexaenoic acid, J. Neurochem. 69 (1997) 504-513.
107. N.P. Rotstein, L.E. Politi, M.I. Aveldaño, Docosahexaenoic acid promotes differentiation of developing photoreceptors in culture, Invest. Ophthalmol. Vis. Sci. 39 (1998) 2750-2758.
108. N.P. Rotstein, L.E. Politi, O.L. German, R. Girotti, Protective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptors, Invest. Ophthalmol. Vis. Sci. 44 (2003) 2252-2259.
109. M. Akbar, H.Y. Kim, Protective effects of docosahexaenoic acid in staurosporine-induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway, J. Neurochem. 82 (2002) 655-665.
110. R.A. Siddiqui, J. Wiesehan, W. Stillwel, L. Jenski, R. Kovacs, Prevention of cytotoxic effects of docosahexaenoic acid in Jurkat leukemic cells by phosphatidic acid, FASEB J. 15 (2001) A282.
111. R.A. Siddiqui, L.J. Jenski, K.A. Harvey, J.D. Wiesehan, W. Stillwell, G.P. Zaloga, Cell-cycle arrest in Jurkat leukaemic cells: a possible role for docosahexaenoic acid, Biochem. J. 371 (2003) 621-629.
112. M. Martínez, E. Vázquez, M.T. García-Silva, J. Manzanares, J.M. Bertran, F. Castelló, I. Mougan, Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders, Am. J. Clin. Nutr. 71 (2000) 376S-385S.
113. H.W. Moser, Peroxisomal disorders, Clin. Biochem. 24 (1991) 343-351.
114. J.R. Hibbeln, N. Salem Jr, Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy, Am. J. Clin. Nutr. 62 (1995) 1-9.
115. D.F. Horrobin, C.N. Bennett, Phospholipid metabolism and the pathophysiology of psychiatric and neurological disorders, in: M. Peet, L. Glen, D.F. Horrobin (Eds.), Phospholipid Spectrum Disorders in Psychiatry and Neurology, Marius Press, Camforth, Lancashire, 2003, pp. 3-47.
116. S. Yoshida, A. Sato, H. Okuyama, Pathophysiological effects of dietary essential fatty acid balance on neural systems, Jpn. J. Pharmacol. 77 (1998) 11-22.
117. J.R. Burgess, L. Stevens, W. Zhang, L. Peck, Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder, Am. J. Clin. Nutr. 71 (2000) 327S-330S.
118. S.P. Mahadik, S. Mukherjee, D.F. Horrobin, K. Jenkins, E.E. Correnti, R.E. Scheffer, Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjects, Psychiatry Res. 63 (1996) 133-142.
119. D. van West, M. Maes, Fatty acid composition in major depression, in: M. Peet, L. Glen, D.F. Horrobin (Eds.), Phospholipid Spectrum Disorders in Psychiatry and Neurology, Marius Press, Carnforth, Lancashire, 2003, pp. 423-429.
120. I. Nordvik, K.M. Myhr, H. Nyland, K.S. Bjerve, Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients, Acta Neurol. Scand. 102 (2000) 143-149.
121. S. Gamoh, M. Hashimoto, K. Sugioka, M.S. Hossain, N. Hata, Y. Misawa, S. Masumura, Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats, Neuroscience 93 (1999) 237-241.
122. M. Okada, T. Amamoto, M. Tomonaga, A. Kawachi, K. Yazawa, K. Mine, M. Fujiwara, The chronic administration of docosahexaenoic acid reduces the spatial cognitive deficit following transient forebrain ischemia in rats, Neuroscience 71 (1996) 17-25.
123. G.E. Billman, H. Hallaq, A. Leaf, Prevention of ischemia-induced ventricular fibrillation by ω-3 fatty acids, Proc. Natl. Acad. Sci. USA 91 (1994) 4427-4430.
124. T. Terano, S. Fujishiro, T. Ban, K. Yamamoto, T. Tanaka, Y. Noguchi, Y. Tamura, K. Yazawa, T. Hirayama, Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases, Lipids 34 (Suppl.) (1999) S345-S346.
125. M.S. Hossain, M. Hashimoto, S. Masumura, Influence of docosahexaenoic acid on cerebral lipid peroxide level in aged rats with and without hypercholesterolemia, Neurosci. Lett. 244 (1998) 157-160.
126. M.S. Hossain, M. Hashimoto, S. Gamoh, S. Masumura, Antioxidative effects of docosahexaenoic acid in the cerebrum versus cerebellum and brainstem of aged hypercholesterolemic rats, J. Neurochem. 72 (1999) 1133-1138.
127. M. Martínez, Severe deficiency of docosahexaenoic acid in peroxisomal disorders: a defect of delta 4 desaturation? Neurology 40 (1990) 1292-1298.
128. M. Martínez, Docosahexaenoic acid therapy in docosahexaenoic acid-deficient patients with disorders of peroxisomal biogenesis, Lipids 31 (1996) S145-S152.
129. J.P. Infante, V.A. Huszagh, Zellweger syndrome knockout mouse models challenge putative peroxisomal beta-oxidation involvement in docosahexaenoic acid (22: 6n-3) biosynthesis, Mol. Genet. Metab. 72 (2001) 1-7.
130. T. Hamazaki, S. Sawazaki, M. Itomura, E. Asaoka, Y. Nagao, N. Nishimura, K. Yazawa, T. Kuwamori, M. Kobayashi, The effect of docosahexaenoic acid on aggression in young adults - a placebo-controlled double-blind study, J. Clin. Invest. 97 (1996) 1129-1133.